Last reviewed · How we verify

NCT03951779

Diagnostic Utility of Exercise Cardiac Magnetic Resonance in the Assessment of Cardiac Dyspnea.

Completed NA Last updated 7 April 2022
What this trial tests

NA trial testing Exercise cardiac magnetic resonance imaging in Shortness of Breath in 9 participants. Completed in 10 January 2020.

Timeline
14 December 2018
Primary endpoint
10 January 2020
10 January 2020

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment9
Start date14 December 2018
Primary completion10 January 2020
Estimated completion10 January 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Shortness of Breath or Cardiac; Dyspnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are examining the diagnostic utility of an exercise cardiac MRI (eCMR) in the assessment of cardiac dyspnea (shortness of breath).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shortness of Breath

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing